Cargando…
Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high bloo...
Autores principales: | Zhu, Qiu-Li, Xu, Wang-Hong, Tao, Meng-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835101/ https://www.ncbi.nlm.nih.gov/pubmed/24281091 http://dx.doi.org/10.3390/cancers2020721 |
Ejemplares similares
-
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
por: Dong, Shuwen, et al.
Publicado: (2021) -
Autoantibodies as Potential Biomarkers in Breast Cancer
por: Qiu, Jingyi, et al.
Publicado: (2018) -
Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism
por: Li, Ling-Rui, et al.
Publicado: (2023) -
Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
por: Chen, Jing, et al.
Publicado: (2020) -
MRI as a biomarker for breast cancer diagnosis and prognosis
por: Galati, Francesca, et al.
Publicado: (2022)